$NMRA
Neumora Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Watertown, MA
NMRA chart
What traders are saying about $NMRA
Latest postsNeumora Therapeutics, Inc. news
- Neumora Therapeutics, Inc. (NASDAQ:NMRA) Stock Rated "Moderate Buy" by Sell-Side Analysts
MarketBeat ·
- Neumora Therapeutics (NASDAQ:NMRA) Upgraded to Sell at Wall Street Zen
MarketBeat ·
- 12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga ·
- Neumora Therapeutics, Inc. (NMRA) Seasonal returns chart
Yahoo Finance UK ·
- Analysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO) and Summit Therapeutics (SMMT)
The Globe and Mail ·
- Biotech Options Buzz: UTHR, NMRA, EWTX
Yahoo Finance ·
- ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
Yahoo Finance ·
- Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Yahoo Finance ·
- Neumora Therapeutics (NMRA) Stock Sees Fair Value Falls After Navacaprant Discontinuation
Yahoo Finance ·
- Why Neumora Therapeutics, Inc. (NMRA) Is One of the Best Get Rich Quick Stocks to Buy
Yahoo Finance ·
- LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential
Yahoo Finance ·
Neumora Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $236.9M | $243.8M | -$235.9M | -$130.9M |
| Diluted EPS | $-1.45 | $-1.53 | $-3.63 | $-4.81 |
| Total assets (year end) | $191.0M | $317.0M | $496.2M | $426.2M |
| Cash and equivalents (year end) | $182.5M | $142.1M | $374.0M | $240.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Neumora Therapeutics, Inc.
- Ticker
- NMRA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Watertown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1885522
Frequently asked questions
What exchange is Neumora Therapeutics, Inc. listed on?
Neumora Therapeutics, Inc. trades on the Nasdaq under the ticker symbol NMRA.
What industry is Neumora Therapeutics, Inc. in?
Neumora Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Neumora Therapeutics, Inc. headquartered?
Neumora Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.
When does Neumora Therapeutics, Inc.'s fiscal year end?
Neumora Therapeutics, Inc.'s fiscal year ends on December 31.